GSK (GSK,GSK.L,GS71.DE) reported first quarter pretax profit of 2.14 billion pounds compared to 2.11 billion pounds, prior year. Earnings per share was 42.6 pence compared to 39.3 pence. Core operating profit was 2.65 billion pounds, up 5% AER, and up 10% CER. Core EPS was 46.5 pence, up 4% AER, and up 9% CER. First quarter total sales were 7.6 billion pounds, up 2% AER, and up 5% CER.
GSK affirmed full-year 2026 guidance at constant exchange rates. The company expects 2026 turnover growth of between 3% to 5%; core operating profit growth of between 7% to 9%; and core EPS growth of between 7% to 9%.
At last close, GSK shares were trading at 2,027.50 pence, down 0.025%.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.